(Q34734838)

4 August 2017

1 reference

title

Genotyping of drug targets: a method to predict adverse drug reactions? (English)

1 reference

4 August 2017

1 reference

2

Olav Spigset

1 reference

4 August 2017

Cüneyt Güzey

1

1 reference

4 August 2017

publication date

1 January 2002

1 reference

4 August 2017

1 reference

4 August 2017

volume

25

1 reference

4 August 2017

issue

8

1 reference

4 August 2017

page(s)

553-560

1 reference

Association between the serotonin 2A receptor gene and tardive dyskinesia in chronic schizophrenia

4 August 2017

cites work

1 reference

12 December 2020

High risk of cerebral-vein thrombosis in carriers of a prothrombin-gene mutation and in users of oral contraceptives

1 reference

12 December 2020

Genetic variations in HLA-B region and hypersensitivity reactions to abacavir

1 reference

12 December 2020

Large-scale genotyping by mass spectrometry: experience, advances and obstacles

1 reference

12 December 2020

Dopamine D3-receptor gene variant and susceptibility to tardive dyskinesia in schizophrenic patients

1 reference

12 December 2020

Gene expression microarray analysis in cancer biology, pharmacology, and drug development: progress and potential.

1 reference

12 December 2020

Maximizing the value of medicines by including pharmacogenetic research in drug development and surveillance

1 reference

12 December 2020

Polysubstance abuse-vulnerability genes: genome scans for association, using 1,004 subjects and 1,494 single-nucleotide polymorphisms

1 reference

12 December 2020

Pharmacogenomics and addiction to opiates

1 reference

12 December 2020

Low penetrance in the long-QT syndrome: clinical impact

1 reference

12 December 2020

Factor V Leiden: should we screen oral contraceptive users and pregnant women?

1 reference

12 December 2020

Association of the MscI polymorphism of the dopamine D3 receptor gene with tardive dyskinesia in schizophrenia

1 reference

12 December 2020

Association between the serotonin 2C receptor gene and tardive dyskinesia in chronic schizophrenia: additive contribution of 5-HT2Cser and DRD3gly alleles to susceptibility.

1 reference

12 December 2020

Geographical/interracial differences in polymorphic drug oxidation. Current state of knowledge of cytochromes P450 (CYP) 2D6 and 2C19

1 reference

12 December 2020

A common polymorphism associated with antibiotic-induced cardiac arrhythmia

1 reference

12 December 2020

Genome complexity reduction for SNP genotyping analysis

1 reference

12 December 2020

Changes in the pharmacokinetics and electrocardiographic pharmacodynamics of terfenadine with concomitant administration of erythromycin

1 reference

12 December 2020

Interaction between the G20210A mutation of the prothrombin gene and oral contraceptive use in deep vein thrombosis

1 reference

12 December 2020

Aetiology of malignant hyperthermia

1 reference

12 December 2020

A molecular basis for cardiac arrhythmia: HERG mutations cause long QT syndrome

1 reference

12 December 2020

The role of the skeletal muscle ryanodine receptor gene in malignant hyperthermia

1 reference

12 December 2020

Increased risk of venous thrombosis in oral-contraceptive users who are carriers of factor V Leiden mutation

1 reference

12 December 2020

Guidelines for molecular genetic detection of susceptibility to malignant hyperthermia.

1 reference

12 December 2020

A map of human genome sequence variation containing 1.42 million single nucleotide polymorphisms

1 reference

12 December 2020

MiRP1 forms IKr potassium channels with HERG and is associated with cardiac arrhythmia

1 reference

12 December 2020

Positional cloning of a novel potassium channel gene: KVLQT1 mutations cause cardiac arrhythmias

1 reference

12 December 2020

Clinical trials in pharmacogenetics and pharmacogenomics: methods and applications

1 reference

12 December 2020

1 reference

12 December 2020

Association between presence of HLA-B*5701, HLA-DR7, and HLA-DQ3 and hypersensitivity to HIV-1 reverse-transcriptase inhibitor abacavir

1 reference

12 December 2020

Diagnosis of susceptibility to malignant hyperthermia in man.

1 reference

12 December 2020

KVLQT1 C-terminal missense mutation causes a forme fruste long-QT syndrome

1 reference

12 December 2020

SCN5A mutations associated with an inherited cardiac arrhythmia, long QT syndrome

1 reference

12 December 2020

Genotypic association between the dopamine D3 receptor and tardive dyskinesia in chronic schizophrenia

1 reference

12 December 2020

Incidence of adverse drug reactions in hospitalized patients: a meta-analysis of prospective studies

1 reference

12 December 2020

Perspectives and challenges for DNA microarrays in drug discovery and development

1 reference

12 December 2020

Predicting effective drug concentrations for individual patients. Determinants of pharmacodynamic variability

1 reference

12 December 2020

Advances in protein microarray technology for protein expression and interaction profiling.

1 reference

12 December 2020

Testing drug response in the presence of genetic information: sampling issues for clinical trials

1 reference

12 December 2020

Extrapyramidal side effects, tardive dyskinesia, and the concept of atypicality.

1 reference

12 December 2020

10.2165/00002018-200225080-00002

Identifiers

DOI

1 reference

Dimensions Publication ID

4 August 2017

1029700141

0 references

1 reference